Gentherm Partners with KNB Communications to Launch Innovative Patient Safety System
- Gentherm partners with KNB Communications to launch the ThermAffyx™ Patient Safety System for enhanced surgical patient care.
- The collaboration emphasizes strategic communications to elevate awareness of Gentherm's medical innovations in the healthcare sector.
- Gentherm submitted a 510(k) premarket notification for ThermAffyx, reinforcing its commitment to patient safety and surgical outcomes.
Gentherm and KNB Communications Forge Strategic Partnership for Patient Safety Innovation
Gentherm, a frontrunner in thermal management and pneumatic comfort technologies, broadens its influence in the healthcare sector by partnering with KNB Communications, a renowned healthcare marketing and public relations agency. Announced on March 10, 2026, this collaboration focuses on the launch of the ThermAffyx™ Patient Safety System, an advanced device designed to enhance patient warming and securement during surgical procedures. Steve Fletcher, Gentherm's Senior Vice President & General Manager, emphasizes the urgency of this development, as the system addresses significant clinical needs identified by surgeons. The ThermAffyx system represents a comprehensive solution, resolving challenges that have long been obstacles to optimal patient care during surgery.
With KNB Communications serving as the official agency of record for Gentherm's medical division, the partnership is poised to leverage specialized expertise in strategic communications and media relations. Chintan Shah, President of KNB Communications, articulates a vision of translating the complexities of medical innovations like the ThermAffyx system into compelling narratives that resonate with key stakeholders including clinicians, investors, and patients. This emphasis on clear communication underpins the overall strategy to elevate the profile of the ThermAffyx system and, by extension, Gentherm’s role in the healthcare market.
In earlier developments this year, Gentherm took proactive steps by submitting a 510(k) Class II premarket notification to the FDA for its ThermAffyx Patient Safety System. With clearance expected in May, this represents a crucial milestone that reinforces Gentherm's commitment to expanding its footprint in the medical device sector. The anticipated integration of advanced thermal management technology into surgical practice contributes to both patient safety and improved surgical outcomes, showcasing Gentherm’s dedication to revolutionizing healthcare through innovation.
Beyond this partnership, Gentherm continues to be recognized for its contributions to automotive comfort technologies, underscoring its leadership in both automotive and healthcare markets. With a portfolio that includes Climate Control Seats (CCS®), Gentherm's dual focus on enhancing comfort and safety positions the company optimally for future growth. The collaboration with KNB Communications not only aims to raise awareness of its medical solutions but also marks a strategic advancement in Gentherm’s mission to innovate healthcare technologies that prioritize patient welfare.
